Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database-Reference-Cited by-同舟云学术

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

Published:2015-12 Issue:13 Volume:13 Page:2333-2341.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Kaplan David E.,Dai Feng,Aytaman Ayse,Baytarian Michelle,Fox Rena,Hunt Kristel,Knott Astrid,Pedrosa Marcos,Pocha Christine,Mehta Rajni,Duggal Mona,Skanderson Melissa,Valderrama Adriana,Taddei Tamar H.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Surgery and portal hypertension;Child,1964

2. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies;D'Amico;J Hepatol,2006

3. Transection of the oesophagus for bleeding oesophageal varices;Pugh;Br J Surg,1973

4. Systematic review: the model for end-stage liver disease—should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?;Cholongitas;Aliment Pharmacol Ther,2005

5. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients;Farnsworth;Am J Surg,2004

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma;2024-08-08

2. Delivery of Outpatient Cirrhosis Care Through Tele-Visit Is Not Associated With Increased Mortality as Compared With Traditional In-Person Visits;American Journal of Gastroenterology;2024-07-25

3. Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure;JAMA Network Open;2024-07-10

4. Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease;Hepatology Communications;2024-07

5. Safety of naltrexone in patients with cirrhosis;JHEP Reports;2024-07